Dynamin: A Target for Novel Anti-epileptic Drugs
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Drugs in Development
Phase Of Development
Preclinical
Sponsors and Collaborators
Children's Medical Research Institute; The University of Sydney; BioLink, EF, FACES
Mechanism of Action
Other
Mechanism Description
modulation of the GTPase activity of dynamin isoform 1
Populations Tested In
N/A
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link